Profile

Originating from German and Sweden, Timo Minssen is a Professor in Technology Law at the University of Copenhagen (UCPH), Denmark, and the Founding Director of UCPH's Center for Advanced Studies in Bioscience Innovation Law (CeBIL). He is also a Research Affiliate at the University of Cambridge and Harvard Law School. Specializing in Intellectual Property-, Competition-, Data Protection and Regulatory Law, his studies concentrate on a plethora of legal issues emerging in the lifecycle of high technology products and processes -  from the regulation of research and incentives for innovation, to technology transfer and commercialization. He focuses in particular on highly regulated sectors, such as emerging technologies in the health and life sciences. At UCPH he leads large interdisciplinary research projects examining legal issues in various applications of AI, quantum technologies, advanced medical computing, synthetic biology, genome editing, precision medicine, biologics, and research infrastructures. He is also the PI of a large international and collaborative research program that is funded by the Novo Nordisk Foundation, and involves an international network of renowned core-partners including inter alia the University of Cambridge, Harvard Law School, Harvard Medical School, and the Danish Technical University (DTU). Moreover, he is scientific advisory board member of the Copenhagen Centre for Regulatory Sciences, the Munich Intellectual Property Law Center (MIPLC), and a steering committee member of the Danish Association for the Protection of Industrial Property. Timo has also served as legal advisor in the private sector, as well as in several WHO AI committees, EU Commission studies, and national committees.

---